Megan Louque
Community Health/Public Health · Mandeville, LANPI 1447253794
Payments from drug & device makers
Across 58 payments — averaging $103.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$846
- AstraZeneca$660
- Phathom Pharmaceuticals, Inc.$475
- Novo Nordisk$470
- AbbVie$398
- Johnson & Johnson$347
- plus $3K from 22 others
What the payments were for
- Food & beverage$5,980100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 8 | $846 |
| AstraZeneca(2 entities) | 6 | $660 |
| Phathom Pharmaceuticals, Inc. | 4 | $475 |
| Novo Nordisk | 4 | $470 |
| AbbVie | 4 | $398 |
| Johnson & Johnson(2 entities) | 3 | $347 |
| Dexcom, Inc. | 2 | $255 |
| Abbott | 2 | $238 |
| Gilead | 2 | $215 |
| Teva Pharmaceuticals USA, Inc. | 2 | $203 |
| Terumo Medical Corporation | 2 | $192 |
| Bayer | 2 | $147 |
| Edwards Lifesciences | 1 | $142 |
| Kyowa Kirin, Inc. | 1 | $118 |
| Ardelyx, Inc. | 1 | $115 |
| Neurocrine Biosciences, Inc. | 1 | $104 |
| Tris Pharma Inc | 1 | $102 |
| Idorsia Pharmaceuticals US Inc | 1 | $100 |
| Lilly USA, LLC | 1 | $99 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $97 |
| Merck | 1 | $97 |
| Cardiovascular Systems Inc. | 1 | $96 |
| Sanofi-aventis U.S. LLC | 1 | $96 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $94 |
| Sanofi | 1 | $77 |
| Inspire Medical Systems, Inc. | 1 | $75 |
| Coloplast | 2 | $73 |
| Lundbeck LLC | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$674
- VOQUEZNA$475
- DEXCOM G7 GSS (161)$255
- Epclusa$215
- RYBELSUS$125
- FreeStyle Libre 2$123
- DEXCOM STELO GLUCOSE BIOSENSOR$122
- Ozempic$118
- FREESTYLE LIBRE 3$115
- XARELTO$115
- IBSRELA$115
- AIRSUPRA$115
- Austedo XR$107
- FARXIGA$103
- Dyanavel XR$102
- VRAYLAR$101
- Navicross$100
- GLIDESHEATH SLENDER$100
- METACROSS OTW$100
- R2P MISAGO$100
How this compares
Too few community health/public health providers in Louisianato place this figure against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.